Evidence map›Paper›PMID 37442111›Full record

ReviewCardiology2023

Quality of Life Measures in Aortic Stenosis Research: A Narrative Review.

Derk Frank, Simon Kennon, Nikolaos Bonaros, Mauro Romano, Carlo Di Mario, Dirk-Jan van Ginkel, Wilbert Bor, Markus Kasel, Ole De Backer, Violetta Hachaturyan and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 10 countries.

Derk FrankDepartment of Internal Medicine III (Cardiology, Angiology and Critical Care), UKSH University Clinical Center Schleswig-Holstein and DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, Kiel, Germany.
Simon KennonDepartment of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
Nikolaos BonarosDepartment of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria.
Mauro RomanoDepartment of Thoracic and Cardiovascular Surgery, Department of Interventional Cardiology, Hôpital Privé Jacques Cartier, Massy, France.
Carlo Di MarioStructural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.
Dirk-Jan van GinkelDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Wilbert BorDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Markus KaselDepartment of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
Ole De BackerInterventional Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Violetta HachaturyanInstitute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
Claudia M LüskeInstitute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
Jana KurucovaEdwards Lifesciences, Prague, Czechia.
Peter BramlageInstitute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
Rima StyraDepartment of Psychiatry, University Health Network, Toronto, Ontario, Canada.
IPPMed (Germany) · DESt. Antonius Ziekenhuis · NLUniversity of Zurich · CHEdwards Lifesciences (United States) · USGerman Centre for Cardiovascular Research · DEHôpital Privé Jacques Cartier · FRInnsbruck Medical University · ATRigshospitalet · DKSt Bartholomew's Hospital · GBUniversity Health Network · CAUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElderly patients with aortic stenosis (AS) not only have a reduced life expectancy but also a reduced quality of life (QoL). The benefits of an AS intervention may be considered a balance between a good QoL and a reasonably extended life. However, the different questionnaires being used to determine the QoL were generally not developed for the specific situation of patients with AS and come with strengths and considerable weaknesses. The objective of this article was to provide an overview of the available QoL instruments in AS research, describe their strengths and weaknesses, and provide our assessment of the utility of the available scoring instruments for QoL measurements in AS. SUMMARY: We identified and reviewed the following instruments that are used in AS research: Short Form Health Survey (SF-36/SF-12), EuroQol-5D (EQ-5D), the Illness Intrusiveness Rating Scale (IIRS), the HeartQoL, the Kansas City Cardiomyopathy Questionnaire (KCCQ), the Minnesota Living with Heart Failure Questionnaire (MLHF), the MacNew Questionnaire, and the Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ). KEY MESSAGES: There is no standardized assessment of QoL in patients with AS. Many different questionnaires are being used, but they are rarely specific for AS. There is a need for AS-specific research into the QoL of patients as life prolongation may compete for an improved QoL in this elderly patient group.

Indexed as

Aortic Valve StenosisHeart FailureAgedHumansQuality of LifeSurveys and QuestionnairesAortic stenosisQuality of lifeQuality of life measuresReview

Identifiers

PMID37442111
PMCPMC10733944
OpenAlexW4384277097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.